{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:15:57Z","timestamp":1790025357785,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.jneuroim.2005.05.002","type":"journal-article","created":{"date-parts":[[2005,6,22]],"date-time":"2005-06-22T16:22:42Z","timestamp":1119457362000},"page":"139-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":263,"title":["Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages"],"prefix":"10.1016","volume":"165","author":[{"given":"Juan C.","family":"Mayo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Sainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dun-Xian","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"Hardeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefa","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russel J.","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2005.05.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-079X.2003.02112.x","article-title":"The chemistry of melatonin's interaction with reactive species","volume":"34","author":"Allegra","year":"2003","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib2","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/sj.bjp.0704365","article-title":"COX-2 and cancer: a new approach to an old problem","volume":"134","author":"Bakhle","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/431405a","article-title":"Cancer: an inflammatory link","volume":"431","author":"Balkwill","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2005.05.002_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1600-079X.2004.00168.x","article-title":"Melatonin protects against pancreaticobiliary inflammation and associated remote organ injury in rats: role of neutrophils","volume":"37","author":"Barlas","year":"2004","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1568026023394407","article-title":"Melatonin as a chronobiotic\/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy","volume":"2","author":"Blask","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1034\/j.1600-079X.2003.00010.x","article-title":"Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition","volume":"34","author":"Chung","year":"2003","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2003.12.009","article-title":"Neuroinflammation, COX-2, and ALS\u2013A dual role?","volume":"187","author":"Consilvio","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0014-2999(98)00673-6","article-title":"Protective effects of melatonin in zymosan-activated plasma-induced paw inflammation","volume":"363","author":"Costantino","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib9","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1096\/fasebj.13.12.1537","article-title":"Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats","volume":"13","author":"Crespo","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib10","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2174\/0929867043365396","article-title":"Potential therapeutic effect of antioxidant therapy in shock and inflammation","volume":"11","author":"Cuzzocrea","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ijc.20639","article-title":"Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9","volume":"113","author":"Ding","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jneuroim.2005.05.002_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1099-1263(200001\/02)20:1<21::AID-JAT623>3.0.CO;2-M","article-title":"In vitro effects of melatonin on cell proliferation in a colon adenocarcinoma line","volume":"20","author":"Farriol","year":"2000","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-079X.2004.00164.x","article-title":"Melatonin reduces amyloid beta-induced apoptosis in pheochromocytoma (PC12) cells","volume":"37","author":"Feng","year":"2004","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-079X.2004.00144.x","article-title":"Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease","volume":"37","author":"Feng","year":"2004","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1096\/fasebj.12.9.685","article-title":"Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkappaB activation","volume":"12","author":"Gilad","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1562\/0031-8655(2003)078<0633:STBCCI>2.0.CO;2","article-title":"Susceptibility to basal cell carcinoma is associated with high dermal mast cell prevalence in non-sun-exposed skin for an Australian populations","volume":"78","author":"Grimbaldeston","year":"2003","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1568026023394335","article-title":"Melatonin-immune system relationships","volume":"2","author":"Guerrero","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1034\/j.1600-079X.2003.00040.x","article-title":"Non-vertebrate melatonin","volume":"34","author":"Hardeland","year":"2003","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0006-291X(84)90732-0","article-title":"N-acetyl-5-methoxykynurenamine, a brain metabolite of melatonin, is a potent inhibitor of prostaglandin biosynthesis","volume":"121","author":"Kelly","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib21","first-page":"1348","article-title":"COX-2 inhibition and the control of pain","volume":"3","author":"Kiefer","year":"2002","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.jneuroim.2005.05.002_bib22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1124\/mol.58.5.967","article-title":"Structure-related inhibition of calmodulin-dependent neuronal nitric-oxide synthase activity by melatonin and synthetic kynurenines","volume":"58","author":"Leon","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1034\/j.1600-079X.2003.00077.x","article-title":"Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro","volume":"35","author":"Leon-Blanco","year":"2003","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib24","first-page":"157","article-title":"Melatonin as a new possible anti-inflammatory agent","volume":"11","author":"Lissoni","year":"1997","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.jneuroim.2005.05.002_bib25","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0197-4580(01)00289-5","article-title":"Inflammation, autotoxicity and Alzheimer disease","volume":"22","author":"McGeer","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.jneuroim.2005.05.002_bib26","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0006-291X(87)91569-5","article-title":"N-acetyltransferase activity, hydroxyindole-O-methyltransferase activity, and melatonin levels in the Harderian glands of the female Syrian hamster: changes during the light:dark cycle and the effect of 6-parachlorophenylalanine administration","volume":"145","author":"Menendez-Pelaez","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points of control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2005.05.002_bib28","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1007\/s00280-004-0887-x","article-title":"Prevention of colorectal cancer through the use of COX-2 selective inhibitors","volume":"54","author":"Peek","year":"2004","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1034\/j.1600-079X.2003.00014.x","article-title":"Melatonin reduces nitric oxide level during ischemia but not blood\u2013brain barrier breakdown during reperfusion in a rat middle cerebral artery occlusion stroke model","volume":"34","author":"Pei","year":"2003","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib30","doi-asserted-by":"crossref","first-page":"L455","DOI":"10.1016\/0024-3205(94)00532-X","article-title":"Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum","volume":"55","author":"Pozo","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0014-2999(00)00196-5","article-title":"Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice","volume":"395","author":"Raghavendra","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0006-291X(03)00586-2","article-title":"C-Phycocyanin, a selective cyclooxygenase-2 inhibitor, induces apoptosis in lipopolysaccharide-stimulated RAW 264.7 macrophages","volume":"304","author":"Reddy","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib33","doi-asserted-by":"crossref","first-page":"C153","DOI":"10.1016\/0303-7207(91)90087-9","article-title":"Melatonin: the chemical expression of darkness","volume":"79","author":"Reiter","year":"1991","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-079X.2004.00165.x","article-title":"Mechanisms of cancer inhibition by melatonin","volume":"37","author":"Reiter","year":"2004","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib35","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1749-6632.1999.tb08028.x","article-title":"Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism","volume":"890","author":"Reiter","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1179\/135100003225002709","article-title":"Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction","volume":"8","author":"Ressmeyer","year":"2003","journal-title":"Redox Rep."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib37","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0006-291X(03)00230-4","article-title":"Antioxidant activity of melatonin in Chinese hamster ovarian cells: changes in cellular proliferation and differentiation","volume":"302","author":"Sainz","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pros.20155","article-title":"Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism","volume":"63","author":"Sainz","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.jneuroim.2005.05.002_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0303-7207(98)00068-9","article-title":"Nicotinamide-induced apoptosis in insulin producing cells is associated with cleavage of poly(ADP-ribose) polymerase","volume":"139","author":"Saldeen","year":"1998","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1470-2045(05)01720-1","article-title":"COX-2 inhibitors: cancer prevention or cardiovascular risk?","volume":"6","author":"Senior","year":"2005","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib41","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jneuroim.2004.07.015","article-title":"Neutrophils as a specific target for melatonin and kynuramines: effects on cytokine release","volume":"156","author":"Silva","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1025863029529","article-title":"Role of cyclooxygenase-2 in colorectal cancer","volume":"23","author":"Sinicrope","year":"2004","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0304-4165(99)00125-7","article-title":"Identification of highly elevated levels of melatonin in bone marrow: its origin and significance","volume":"1472","author":"Tan","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jneuroim.2005.05.002_bib44","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0891-5849(00)00435-4","article-title":"Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation","volume":"29","author":"Tan","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib45","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/1568026023394443","article-title":"Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger","volume":"2","author":"Tan","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib46","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1034\/j.1600-079X.2003.00037.x","article-title":"Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical","volume":"34","author":"Tan","year":"2003","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev.med.53.082901.103952","article-title":"Cyclooxygenase-2: a therapeutic target","volume":"53","author":"Turini","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib48","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nri1415","article-title":"Inflammation and necrosis promote tumour growth","volume":"4","author":"Vakkila","year":"2004","journal-title":"Nat. Rev., Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.jneuroim.2005.05.002_bib49","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1007\/s000110050284","article-title":"Anti-inflammatory drugs and their mechanism of action","volume":"47","author":"Vane","year":"1998","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin","volume":"110","author":"Vane","year":"2003","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jneuroim.2005.05.002_bib52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1091\/mbc.10.2.361","article-title":"NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages","volume":"10","author":"von Knethen","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jneuroim.2005.05.002_bib53","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-5793(01)02680-1","article-title":"Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cells","volume":"502","author":"Wolfler","year":"2001","journal-title":"FEBS Lett."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572805001724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572805001724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:01:42Z","timestamp":1759046502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572805001724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":53,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0165572805001724"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2005.05.002","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2005.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}